World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01170780
Date of registration: 26/07/2010
Primary sponsor: Mette Astrup Madsen
Public title: Dexamethasone Versus Placebo in Optimizing the Postoperative Period After Laparoscopic Inguinal Hernia Repair
Scientific title: Dexamethasone Versus Placebo in Optimizing the Postoperative Period After Laparoscopic Inguinal Hernia Repair
Date of first enrolment: August 2010
Target sample size: 80
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT01170780
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention  
Countries of recruitment
Denmark
Contacts
Name:   Mette A Tolver, M.D.
Address: 
Telephone:
Email:
Affiliation:  University Hospital Koege
Name:   Thue Bisgaard, M.D. DMSc
Address: 
Telephone:
Email:
Affiliation:  University Hospital Koege
Key inclusion & exclusion criteria

Inclusion Criteria:

- patients planned for elective laparoscopic hernia repair (TAPP)

- Unilateral inguinal or femoral hernia

- ASA class I-II

- Read and speak Danish

Exclusion Criteria:

- Acute hernia operation

- Operation for other hernias with mesh during the same procedure

- Endocrine disease (diabetes, adrenal insufficiency etc.)

- fever/infection within the first 10 days before operation

- Poor compliance

- No signed consent form

- Daily intake of opioids or anxiolytic drugs

- Manic episodes

- Use medicine against glaucoma

- Use thiazide or loop diuretics

- Vaccination within the last 14 days



Age minimum: 18 Years
Age maximum: 85 Years
Gender: Male
Health Condition(s) or Problem(s) studied
Femoral Hernia
Inguinal Hernia
Intervention(s)
Drug: Dexamethasone
Drug: Saline
Primary Outcome(s)
pain during coughing [Time Frame: day 1]
Secondary Outcome(s)
convalescence [Time Frame: 1 month]
discomfort [Time Frame: 4 days]
fatigue [Time Frame: 4 days]
nausea [Time Frame: 2 days]
pain at rest [Time Frame: 4 days]
pain during coughing [Time Frame: 4 days]
vomiting [Time Frame: 2 days]
Secondary ID(s)
dx3
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history